Amgen’s Q2 Revenue Rises 20% Despite Higher Expenses
Amgen's Q2 profit drops due to higher expenses, but revenue sees a 20% increase, driven by Horizon acquisition.
- Latest
- Trending
Amgen's Q2 profit drops due to higher expenses, but revenue sees a 20% increase, driven by Horizon acquisition.
Castle Biosciences reports 74% Q2 revenue surge to $87M, driven by test usage and price hikes, with net income rebounding ...
California harnesses AI for health and social services translations, aiming to improve access while ensuring human oversight for accuracy and ...
"AI in Medical Diagnostics set to skyrocket to USD 30.76 billion by 2032, driven by rapid advancements and major industry ...
Explore conflicting analyst opinions on Alnylam's HELIOS-B data, contrasting efficacy views for vutrisiran in addressing ATTR-CM treatments.
Novo Nordisk's $4.1B Clayton investment creates 1,000 jobs, boosts local economy, and enhances life science growth in North Carolina.
Artificial Intelligence in Ultrasound Imaging Market to grow from USD 889.16 million in 2023 to USD 1733.08 million by 2031 ...
"ResMed and Inspire Medical stocks plummet after Eli Lilly's Zepbound trial success; Citi downgrades RMD, sees market shift. Read more ...
America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
"Discover how VR and modified craniotomy techniques enhance brain surgery, improving MMA preservation rates and patient outcomes in MMD and ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.